PORT WASHINGTON, New York—Drive DeVilbiss Healthcare, a respiratory care company, launched the “PulmO2” oxygen concentrator, a solution aiming to improve access to oxygen therapy in low- and middle-income countries. With over a million annual preventable deaths from hypoxemia in these regions, the PulmO2 intends to address a gap in health care.
The PulmO2's features, listed below, can be highly effective in resource-limited settings.
- Energy efficiency: Can reduce energy use by up to 67% for areas with limited electricity.
- Solar compatibility: A gentle start-up allows for solar power integration.
- Wide voltage range: Adaptable to varied power environments, such as 100-240 volts alternating current (VAC) or 50-60 hertz.
- Durability: Offers performance in extreme conditions, including high temperatures, humidity and dusty environments.
- High altitude operations: Tested and rated, allowing for use up to 2,000 meters or 6,562 feet.
- User-centric model: Includes multi-language labels and QR codes, aiming to provide quick access to information, such as a library of videos that explain how to operate and repair the device.
"Our mission has always been to lead in creating innovative health care solutions that improve lives," said Derek Lampert, CEO of Drive DeVilbiss Healthcare. "The PulmO2 is a testament to our commitment to transforming challenging health care environments. We are proud to partner with Sanrai to ensure that no patient, regardless of location, is left without access to critically important oxygen."
The company said the release of PulmO2 intends to build upon its health care innovation efforts. The company collaborated with Sanrai International, a provider of medical equipment to underserved areas, in order to understand the intricacies of underserved regions and ensure the concentrator is effective in challenging settings.
